Health news
A supplemental Biologics License Application (sBLA) has been submitted to the Food and Drug Administration (FDA) for pegloticase injection plus methotrexate for the treatment of uncontrolled gout. Pegloticase is currently marketed under the brand name…
The Food and Drug Administration (FDA) has granted Fast Track designation to ALLN-346 for the treatment of hyperuricemia in gout patients with advanced chronic kidney disease. ALLN-346 is an investigational, first-in-class, nonabsorbed, orally-administered enzyme that…
Compared with healthy individuals, patients with gout were found to have a significantly unique gut microbiota associated with dysregulated host urate degradation and systemic inflammation, according to study results published in NPJ Biofilms and Microbiomes.…
September 2021 has been declared as both Pain Awareness and Arthritis Awareness Month. An estimated 20% of Americans have chronic pain, with 8.0% of US adults experiencing high-impact chronic pain.1 Gout, one of the most…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021